Cadila Healthcare’sΒ subsidiary, has received approval from the US health regulator for Clozapine tablets, which is used to treat schizophrenia. In a filing the company stated,...
Dr Reddy’s Laboratories has received Establishment Inspection Report (EIR), for itsΒ Miyapur facility, Hyderabad, Telangana. The Custom Pharmaceutical Services facility, of Dr Reddyβs Laboratories at the...
USFDA has given approval toΒ Mylanβs Ogivri, which is a biosimilar of cancer drugΒ Herceptin, co-developed with Biocon.Β Trastuzumab is the generic name of Herceptin. Ogivri has received...
Zydus Cadila has received final approval to marketΒ Candesartan Cilexetil and Hydrochlorothiazide tablets formulations, from the US health regulator. It is used for treating high blood...
Glenmark Pharma’s, Baddi manufacturing unit has received 7 observations, from the US health regulator after an audit. Its Baddi unitΒ contributes approx 10% of the revenue...
Zydus Cadila has received final approvalΒ to market minocycline hydrochloride extended release tablets, which is used for treating acne, from the US health regulator. The drug...
Zydus Cadila has received approval to marketΒ Tadalafil tablets in the US market, from the US health regulator. It is used for treatment ofΒ erectile dysfunction and...
Glenmark Pharmaceuticals has received final approval from the US health regulator, for a generic version of Loestrin tablets, which is used to prevent pregnancy. In...
Strides Shasun’sΒ wholly-owned subsidiary has receivedΒ green signal fromΒ the US health regulator, for Acetazolamide tablets. It is used to prevent and reduce symptoms of altitude sickness. In...
Dr.Reddy’s Laboratories has receivedΒ an establishment inspection report (EIR), for its formulation manufacturing facility at Duvvada in Visakhapatnam, from the US health regulator. The company has...